Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Development ; 148(6)2021 03 15.
Article in English | MEDLINE | ID: mdl-33593819

ABSTRACT

The Evf2 long non-coding RNA directs Dlx5/6 ultraconserved enhancer(UCE)-intrachromosomal interactions, regulating genes across a 27 Mb region on chromosome 6 in mouse developing forebrain. Here, we show that Evf2 long-range gene repression occurs through multi-step mechanisms involving the transcription factor Sox2. Evf2 directly interacts with Sox2, antagonizing Sox2 activation of Dlx5/6UCE, and recruits Sox2 to the Dlx5/6eii shadow enhancer and key Dlx5/6UCE interaction sites. Sox2 directly interacts with Dlx1 and Smarca4, as part of the Evf2 ribonucleoprotein complex, forming spherical subnuclear domains (protein pools, PPs). Evf2 targets Sox2 PPs to one long-range repressed target gene (Rbm28), at the expense of another (Akr1b8). Evf2 and Sox2 shift Dlx5/6UCE interactions towards Rbm28, linking Evf2/Sox2 co-regulated topological control and gene repression. We propose a model that distinguishes Evf2 gene repression mechanisms at Rbm28 (Dlx5/6UCE position) and Akr1b8 (limited Sox2 availability). Genome-wide control of RNPs (Sox2, Dlx and Smarca4) shows that co-recruitment influences Sox2 DNA binding. Together, these data suggest that Evf2 organizes a Sox2 PP subnuclear domain and, through Sox2-RNP sequestration and recruitment, regulates chromosome 6 long-range UCE targeting and activity with genome-wide consequences.


Subject(s)
Chromosomes, Mammalian/genetics , Gene Expression Regulation, Developmental , Prosencephalon/metabolism , RNA, Long Noncoding/genetics , SOXB1 Transcription Factors/genetics , Animals , DNA Helicases/genetics , DNA Helicases/metabolism , Enhancer Elements, Genetic/genetics , Fluorescent Antibody Technique/methods , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , In Situ Hybridization, Fluorescence/methods , Mice, Knockout , Mice, Transgenic , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Prosencephalon/embryology , Protein Binding , RNA, Long Noncoding/metabolism , Ribonucleoproteins/genetics , Ribonucleoproteins/metabolism , SOXB1 Transcription Factors/metabolism , Transcription Factors/genetics , Transcription Factors/metabolism
2.
Mol Cell ; 71(6): 956-972.e9, 2018 09 20.
Article in English | MEDLINE | ID: mdl-30146317

ABSTRACT

Gene regulation requires selective targeting of DNA regulatory enhancers over megabase distances. Here we show that Evf2, a cloud-forming Dlx5/6 ultraconserved enhancer (UCE) lncRNA, simultaneously localizes to activated (Umad1, 1.6 Mb distant) and repressed (Akr1b8, 27 Mb distant) chr6 target genes, precisely regulating UCE-gene distances and cohesin binding in mouse embryonic forebrain GABAergic interneurons (INs). Transgene expression of Evf2 activates Lsm8 (12 Mb distant) but fails to repress Akr1b8, supporting trans activation and long-range cis repression. Through both short-range (Dlx6 antisense) and long-range (Akr1b8) repression, the Evf2-5'UCE links homeodomain and mevalonate pathway-regulated enhancers to IN diversity. The Evf2-3' end is required for long-range activation but dispensable for RNA cloud localization, functionally dividing the RNA into 3'-activator and 5'UCE repressor and targeting regions. Together, these results support that Evf2 selectively regulates UCE interactions with multi-megabase distant genes through complex effects on chromosome topology, linking lncRNA-dependent topological and transcriptional control with interneuron diversity and seizure susceptibility.


Subject(s)
Gene Expression Regulation, Developmental/genetics , Homeodomain Proteins/genetics , Prosencephalon/embryology , Alcohol Oxidoreductases/genetics , Animals , Cell Cycle Proteins/genetics , Chromosomal Proteins, Non-Histone/genetics , Conserved Sequence , Enhancer Elements, Genetic/genetics , Homeodomain Proteins/physiology , Interneurons/physiology , Mice , Neurogenesis/genetics , Neurogenesis/physiology , RNA, Long Noncoding/genetics , Transcription Factors , Cohesins
3.
Genetics ; 206(4): 1895-1907, 2017 08.
Article in English | MEDLINE | ID: mdl-28607146

ABSTRACT

Previously expressed inducible genes can remain poised for faster reactivation for multiple cell divisions, a conserved phenomenon called epigenetic transcriptional memory. The GAL genes in Saccharomyces cerevisiae show faster reactivation for up to seven generations after being repressed. During memory, previously produced Gal1 protein enhances the rate of reactivation of GAL1, GAL10, GAL2, and GAL7 These genes also interact with the nuclear pore complex (NPC) and localize to the nuclear periphery both when active and during memory. Peripheral localization of GAL1 during memory requires the Gal1 protein, a memory-specific cis-acting element in the promoter, and the NPC protein Nup100 However, unlike other examples of transcriptional memory, the interaction with NPC is not required for faster GAL gene reactivation. Rather, downstream of Gal1, the Tup1 transcription factor and growth in glucose promote GAL transcriptional memory. Cells only show signs of memory and only benefit from memory when growing in glucose. Tup1 promotes memory-specific chromatin changes at the GAL1 promoter: incorporation of histone variant H2A.Z and dimethylation of histone H3, lysine 4. Tup1 and H2A.Z function downstream of Gal1 to promote binding of a preinitiation form of RNA Polymerase II at the GAL1 promoter, poising the gene for faster reactivation. This mechanism allows cells to integrate a previous experience (growth in galactose, reflected by Gal1 levels) with current conditions (growth in glucose, potentially through Tup1 function) to overcome repression and to poise critical GAL genes for future reactivation.


Subject(s)
Epigenesis, Genetic , Galactokinase/genetics , Glucose/metabolism , Nuclear Proteins/genetics , Repressor Proteins/genetics , Saccharomyces cerevisiae Proteins/genetics , Chromatin/genetics , Chromatin/metabolism , Galactokinase/metabolism , Galactose/metabolism , Histones/metabolism , Nuclear Pore Complex Proteins/genetics , Nuclear Pore Complex Proteins/metabolism , Nuclear Proteins/metabolism , Promoter Regions, Genetic , Repressor Proteins/metabolism , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/physiology , Saccharomyces cerevisiae Proteins/metabolism
4.
Dev Biol ; 424(2): 221-235, 2017 04 15.
Article in English | MEDLINE | ID: mdl-28263766

ABSTRACT

Sonic hedgehog (SHH) is a master developmental regulator. In 1995, the SHH crystal structure predicted that SHH-E176 (human)/E177 (mouse) regulates signaling through a Zn2+-dependent mechanism. While Zn2+ is known to be required for SHH protein stability, a regulatory role for SHH-E176 or Zn2+ has not been described. Here, we show that SHH-E176/177 modulates Zn2+-dependent cross-linking in vitro and is required for endogenous signaling, in vivo. While ectopically expressed SHH-E176A is highly active, mice expressing SHH-E177A at endogenous sites (ShhE177A/-) are morphologically indistinguishable from mice lacking SHH (Shh-/-), with patterning defects in both embryonic spinal cord and forebrain. SHH-E177A distribution along the embryonic spinal cord ventricle is unaltered, suggesting that E177 does not control long-range transport. While SHH-E177A association with cilia basal bodies increases in embryonic ventral spinal cord, diffusely distributed SHH-E177A is not detected. Together, these results reveal a novel role for E177-Zn2+ in regulating SHH signaling that may involve critical, cilia basal-body localized changes in cross-linking and/or conformation.


Subject(s)
Hedgehog Proteins/chemistry , Hedgehog Proteins/metabolism , Signal Transduction , Zinc/chemistry , Animals , Antibodies/chemistry , Antibodies/metabolism , Antibody Specificity/immunology , Basal Bodies/drug effects , Basal Bodies/metabolism , Base Sequence , Cilia/drug effects , Cilia/metabolism , Cross-Linking Reagents/metabolism , Embryo, Mammalian/drug effects , Embryo, Mammalian/metabolism , Humans , Mice , Prosencephalon/drug effects , Prosencephalon/enzymology , Prosencephalon/metabolism , Protein Conformation , Protein Multimerization/drug effects , Signal Transduction/drug effects , Spinal Cord/drug effects , Spinal Cord/embryology , Spinal Cord/metabolism , Zinc/pharmacology
5.
Development ; 142(15): 2641-52, 2015 Aug 01.
Article in English | MEDLINE | ID: mdl-26138476

ABSTRACT

Transcription-regulating long non-coding RNAs (lncRNAs) have the potential to control the site-specific expression of thousands of target genes. Previously, we showed that Evf2, the first described ultraconserved lncRNA, increases the association of transcriptional activators (DLX homeodomain proteins) with key DNA enhancers but represses gene expression. In this report, mass spectrometry shows that the Evf2-DLX1 ribonucleoprotein (RNP) contains the SWI/SNF-related chromatin remodelers Brahma-related gene 1 (BRG1, SMARCA4) and Brahma-associated factor (BAF170, SMARCC2) in the developing mouse forebrain. Evf2 RNA colocalizes with BRG1 in nuclear clouds and increases BRG1 association with key DNA regulatory enhancers in the developing forebrain. While BRG1 directly interacts with DLX1 and Evf2 through distinct binding sites, Evf2 directly inhibits BRG1 ATPase and chromatin remodeling activities. In vitro studies show that both RNA-BRG1 binding and RNA inhibition of BRG1 ATPase/remodeling activity are promiscuous, suggesting that context is a crucial factor in RNA-dependent chromatin remodeling inhibition. Together, these experiments support a model in which RNAs convert an active enhancer to a repressed enhancer by directly inhibiting chromatin remodeling activity, and address the apparent paradox of RNA-mediated stabilization of transcriptional activators at enhancers with a repressive outcome. The importance of BRG1/RNA and BRG1/homeodomain interactions in neurodevelopmental disorders is underscored by the finding that mutations in Coffin-Siris syndrome, a human intellectual disability disorder, localize to the BRG1 RNA-binding and DLX1-binding domains.


Subject(s)
Chromatin Assembly and Disassembly/physiology , DNA Helicases/metabolism , Gene Expression Regulation/genetics , Homeodomain Proteins/metabolism , Nuclear Proteins/metabolism , Prosencephalon/embryology , RNA, Long Noncoding/metabolism , Ribonucleoproteins/metabolism , Transcription Factors/metabolism , Abnormalities, Multiple/genetics , Animals , Base Sequence , Chromatin Assembly and Disassembly/genetics , Chromatin Immunoprecipitation , DNA Helicases/genetics , DNA Primers/genetics , Face/abnormalities , Hand Deformities, Congenital/genetics , Humans , Immunohistochemistry , In Situ Hybridization, Fluorescence , Intellectual Disability/genetics , Mass Spectrometry , Mice , Micrognathism/genetics , Molecular Sequence Data , Neck/abnormalities , Nuclear Proteins/genetics , RNA, Long Noncoding/genetics , Sequence Analysis, RNA , Transcription Factors/genetics
6.
Development ; 140(21): 4407-16, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24089468

ABSTRACT

Several lines of evidence suggest that long non-coding RNA (lncRNA)-dependent mechanisms regulate transcription and CpG DNA methylation. Whereas CpG island methylation has been studied in detail, the significance of enhancer DNA methylation and its relationship with lncRNAs is relatively unexplored. Previous experiments proposed that the ultraconserved lncRNA Evf2 represses transcription through Dlx6 antisense (Dlx6as) transcription and methyl-CpG binding protein (MECP2) recruitment to the Dlx5/6 ultraconserved DNA regulatory enhancer (Dlx5/6ei) in embryonic day 13.5 medial ganglionic eminence (E13.5 MGE). Here, genetic epistasis experiments show that MECP2 transcriptional repression of Evf2 and Dlx5, but not Dlx6, occurs through antagonism of DLX1/2 in E13.5 MGE. Analysis of E13.5 MGE from mice lacking Evf2 and of partially rescued Evf2 transgenic mice shows that Evf2 prevents site-specific CpG DNA methylation of Dlx5/6ei in trans, without altering Dlx5/6 expression. Dlx1/2 loss increases CpG DNA methylation, whereas Mecp2 loss does not affect Dlx5/6ei methylation. Based on these studies, we propose a model in which Evf2 inhibits enhancer DNA methylation, effectively modulating competition between the DLX1/2 activator and MECP2 repressor. Evf2 antisense transcription and Evf2-dependent balanced recruitment of activator and repressor proteins enables differential transcriptional control of adjacent genes with shared DNA regulatory elements.


Subject(s)
DNA Methylation/physiology , Enhancer Elements, Genetic/physiology , Epistasis, Genetic/physiology , Gene Expression Regulation, Developmental/physiology , Homeodomain Proteins/metabolism , RNA, Long Noncoding/metabolism , Telencephalon/embryology , Animals , Benzothiazoles , DNA Primers/genetics , Diamines , Homeodomain Proteins/genetics , Methyl-CpG-Binding Protein 2/metabolism , Mice , Organic Chemicals , Quinolines , Real-Time Polymerase Chain Reaction
7.
Mol Biol Cell ; 22(15): 2741-53, 2011 Aug 01.
Article in English | MEDLINE | ID: mdl-21680712

ABSTRACT

In Saccharomyces cerevisiae, ubiquitylation of histone H2B signals methylation of histone H3 at lysine residues 4 (K4) and 79. These modifications occur at active genes but are believed to stabilize silent chromatin by limiting movement of silencing proteins away from heterochromatin domains. In the course of studying atypical phenotypes associated with loss of H2B ubiquitylation/H3K4 methylation, we discovered that these modifications are also required for cell wall integrity at high temperatures. We identified the silencing protein Sir4 as a dosage suppressor of loss of H2B ubiquitylation, and we showed that elevated Sir4 expression suppresses cell wall integrity defects by inhibiting the function of the Sir silencing complex. Using comparative transcriptome analysis, we identified a set of euchromatic genes-enriched in those required for the cellular response to heat-whose expression is attenuated by loss of H2B ubiquitylation but restored by disruption of Sir function. Finally, using DNA adenine methyltransferase identification, we found that Sir3 and Sir4 associate with genes that are silenced in the absence of H3K4 methylation. Our data reveal that H2B ubiquitylation/H3K4 methylation play an important role in limiting ectopic association of silencing proteins with euchromatic genes important for cell wall integrity and the response to heat.


Subject(s)
Euchromatin/metabolism , Heterochromatin/metabolism , Histones/metabolism , Saccharomyces cerevisiae/physiology , Silent Information Regulator Proteins, Saccharomyces cerevisiae/metabolism , Site-Specific DNA-Methyltransferase (Adenine-Specific)/metabolism , Cell Wall/genetics , Cell Wall/metabolism , Euchromatin/genetics , Gene Expression Regulation, Fungal , Gene Silencing , Genetic Loci , Genome, Fungal , Heterochromatin/genetics , Histones/genetics , Hot Temperature , Lysine/metabolism , Methylation , Plasmids , Protein Processing, Post-Translational , RNA, Messenger , Sequence Analysis, DNA , Silent Information Regulator Proteins, Saccharomyces cerevisiae/genetics , Site-Specific DNA-Methyltransferase (Adenine-Specific)/genetics , Transcription, Genetic , Transfection , Ubiquitination
8.
Nat Cell Biol ; 12(2): 111-8, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20098417

ABSTRACT

Many genes in Saccharomyces cerevisiae are recruited to the nuclear periphery after transcriptional activation. We have identified two gene recruitment sequences (GRS I and II) from the promoter of the INO1 gene that target the gene to the nuclear periphery. These GRSs function as DNA zip codes and are sufficient to target a nucleoplasmic locus to the nuclear periphery. Targeting requires components of the nuclear pore complex (NPC) and a GRS is sufficient to confer a physical interaction with the NPC. GRS I elements are enriched in promoters of genes that interact with the NPC, and genes that are induced by protein folding stress. Full transcriptional activation of INO1 and another GRS-containing gene requires GRS-mediated targeting of the promoter to the nuclear periphery. Finally, GRS I also functions as a DNA zip code in Schizosaccharomyces pombe, suggesting that this mechanism of targeting to the nuclear periphery has been conserved over approximately one billion years of evolution.


Subject(s)
Cell Nucleus/metabolism , DNA, Fungal/metabolism , Saccharomyces cerevisiae/metabolism , Chromatin Immunoprecipitation , DNA, Fungal/genetics , Genome, Fungal/genetics , Models, Biological , Myo-Inositol-1-Phosphate Synthase/genetics , Nuclear Pore/metabolism , Promoter Regions, Genetic/genetics , Reverse Transcriptase Polymerase Chain Reaction , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae Proteins/genetics , Schizosaccharomyces/metabolism
9.
PLoS Biol ; 5(4): e81, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17373856

ABSTRACT

Many genes are recruited to the nuclear periphery upon transcriptional activation. The mechanism and functional significance of this recruitment is unclear. We find that recruitment of the yeast INO1 and GAL1 genes to the nuclear periphery is rapid and independent of transcription. Surprisingly, these genes remain at the periphery for generations after they are repressed. Localization at the nuclear periphery serves as a form of memory of recent transcriptional activation, promoting reactivation. Previously expressed GAL1 at the nuclear periphery is activated much more rapidly than long-term repressed GAL1 in the nucleoplasm, even after six generations of repression. Localization of INO1 at the nuclear periphery is necessary and sufficient to promote more rapid activation. This form of transcriptional memory is chromatin based; the histone variant H2A.Z is incorporated into nucleosomes within the recently repressed INO1 promoter and is specifically required for rapid reactivation of both INO1 and GAL1. Furthermore, H2A.Z is required to retain INO1 at the nuclear periphery after repression. Therefore, H2A.Z-mediated localization of recently repressed genes at the nuclear periphery represents an epigenetic state that confers memory of transcriptional activation and promotes reactivation.


Subject(s)
Cell Nucleus/genetics , Epigenesis, Genetic , Histones/physiology , Transcription, Genetic , Base Sequence , Chromatin Immunoprecipitation , DNA Primers , Reverse Transcriptase Polymerase Chain Reaction , Saccharomyces cerevisiae Proteins/genetics
10.
Am J Hum Genet ; 76(6): 987-1007, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15858711

ABSTRACT

Matsumoto and colleagues recently identified PEX26 as the gene responsible for complementation group 8 of the peroxisome biogenesis disorders and showed that it encodes an integral peroxisomal membrane protein with a single C-terminal transmembrane domain and a cytosolic N-terminus that interacts with the PEX1/PEX6 heterodimer through direct binding to the latter. They proposed that PEX26 functions as the peroxisomal docking factor for the PEX1/PEX6 heterodimer. Here, we identify new PEX26 disease alleles, localize the PEX6-binding domain to the N-terminal half of the protein (aa 29-174), and show that, at the cellular level, PEX26 deficiency impairs peroxisomal import of both PTS1- and PTS2-targeted matrix proteins. Also, we find that PEX26 undergoes alternative splicing to produce several splice forms--including one, PEX26- delta ex5, that maintains frame and encodes an isoform lacking the transmembrane domain of full-length PEX26 (PEX26-FL). Despite its cytosolic location, PEX26- delta ex5 rescues peroxisome biogenesis in PEX26-deficient cells as efficiently as does PEX26-FL. To test our observation that a peroxisomal location is not required for PEX26 function, we made a chimeric protein (PEX26-Mito) with PEX26 as its N-terminus and the targeting segment of a mitochondrial outer membrane protein (OMP25) at its C-terminus. We found PEX26-Mito localized to the mitochondria and directed all detectable PEX6 and a fraction of PEX1 to this extraperoxisomal location; yet PEX26-Mito retains the full ability to rescue peroxisome biogenesis in PEX26-deficient cells. On the basis of these observations, we suggest that a peroxisomal localization of PEX26 and PEX6 is not required for their function and that the interaction of PEX6 with PEX1 is dynamic. This model predicts that, once activated in an extraperoxisomal location, PEX1 moves to the peroxisome and completes the function of the PEX1/6 heterodimer.


Subject(s)
Alternative Splicing , Membrane Proteins/genetics , Membrane Proteins/metabolism , Models, Genetic , Peroxisomes/metabolism , Alleles , Amino Acid Sequence/genetics , Cell Line , Chromosome Mapping , Cytosol/metabolism , DNA-Binding Proteins/chemistry , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Exons , Fibroblasts/metabolism , Gene Frequency , Humans , Membrane Proteins/chemistry , Mitochondria/metabolism , Molecular Sequence Data , Mutation, Missense , Pedigree , Peroxisomal Disorders/genetics , Peroxisomal Disorders/metabolism , Peroxisomal Targeting Signal 2 Receptor , Peroxisome-Targeting Signal 1 Receptor , Peroxisomes/chemistry , Protein Isoforms/chemistry , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protein Structure, Tertiary , Receptors, Cytoplasmic and Nuclear/genetics , Receptors, Cytoplasmic and Nuclear/metabolism , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Sequence Homology, Amino Acid , Skin/cytology
SELECTION OF CITATIONS
SEARCH DETAIL
...